Product Images Carvedilol Phosphate

This is a description of Carvedilol Phosphate Extended-Release Capsules in a package containing 30 capsules, each containing 80 mg of carvedilol phosphate. The usual dosage information is available in the prescribing information, and the storage conditions recommend keeping it between 20° to 25°C (68° to 77°F). It emphasizes not using the product if the safety seal is broken or missing, keeping it away from children, and seeking help in case of accidental overdose. The product is distributed by Amneal Pharmaceuticals LLC from Bridgewater, NJ. The packaging includes details of lot number, expiration date, and serialization in a specific area.*

This text provides information on mortality rate associated with Carvedilol for different time intervals (9, 12, 15, 18, and 2 months) with a mortality percentage of 0.14%.*

This text appears to be a list of categories and conditions related to different factors such as gender, age, ethnicity, medical conditions, and medications. It seems to involve categorizing individuals based on these criteria and possibly recording numerical values. The information includes factors like gender (Men, Women), age (<65, >65), race (Black, Non-black), medical conditions (Diabetic, Non-diabetic, Ischemic, Nonischemic), vital signs (Heart rate, SBP), and medication (Spironolactone, No spironolactone). The text also includes numerical references like "0.0, 0.05, 1.0, 1.6, 2.0." It seems like part of a medical or research-related document evaluating different variables.*

This is a data table showing various parameters and features related to a study conducted post myocardial infarction (MI). It includes details such as age, gender, randomized days post MI, prior medical history, treatment procedures, hazard ratios, clinical conditions like Killip classification, use of thrombolytic therapy, PTCA for MI, availability of CHE and CHF, as well as the presence or absence of conditions like angina, hypertension, diabetes, and specific measurements for heart rate and blood pressure. The data seems to be segmented to compare outcomes based on these variables for analysis.*

This is a detailed record of changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP) associated with different dosages of carvedilol phosphate extended-release capsules, including 20mg, 40mg, and 80mg. The data also includes a graph showing the time after morning doses and the corresponding changes in blood pressure. The lines on the graph are smoothed using the locally weighted regression smoothing methodology for accurate analysis.*

Each extended-release capsule contains 10 mg of Carvedilol Phosphate. It is recommended to follow a once-a-day dosing schedule. The medication should be stored at controlled room temperature. Keep the capsules sealed under the cap and out of reach of children. In case of accidental overdose, seek immediate medical help or contact a poison control center. This medication is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. Note that the prescribing information should be consulted for complete details on the usual dosage.*

Each extended-release capsule contains 20 mg of carvedilol. The recommended dosage should be followed as per the prescribing information. The medication should be stored at room temperature. It is important to keep the safety seal under the cap intact. In case of accidental overdose, seek professional help or contact a poison control center immediately. This product is distributed by Amneal Pharmaceuticals LLC.*

This text provides information about a medication called Carvedilol Phosphate Extended-Release Capsules, with each capsule containing 40 mg of carvedilol phosphate. The text includes details on the usual dosage, storage instructions, safety precautions, and manufacturer information. It also reminds users to check for the safety seal, keep the medication out of reach of children, and what to do in case of an accidental overdose. The product is distributed by Amneal Pharmaceuticals LLC.*